Potential side effects and countermeasures of repotinib in Laos

Repotrectinib (Repotrectinib) is a drug that has attracted much attention recently. It is mainly used to treat ROS1-positive non-small cell lung cancer (NSCLC) and solid tumors carrying NTRK gene fusions. As a new type of tyrosine kinase inhibitor (TKI), it effectively curbs the proliferation and spread of tumor cells by precisely inhibiting specific protein kinases, bringing new hope to many cancer patients. However, any drug may be accompanied by some adverse reactions during use, and Ripotinib is no exception.

Patients taking repotinib may experience a range of side effects. Among them, the more common ones include dizziness, abnormal taste, numbness or tingling in the limbs, constipation, nausea, difficulty breathing, and easy fatigue. In addition, some patients may experience slowed thinking, memory loss, hallucinations, or difficulty maintaining body balance, coordinating movements, and walking. These discomforts are usually noticeable at the beginning of treatment, but over time, some patients may gradually adapt and relieve these symptoms.

It is important to be particularly vigilant because Ripotinib may cause more serious side effects in some cases. For example, the impact on the central nervous system may cause patients to experience symptoms such as severe dizziness, disordered thinking, and hallucinations. At the same time, patients may also experience large mood swings, such as feeling anxious, irritable, or falling into depression. Once these new or worsening symptoms occur during treatment, patients should immediately report back to the doctor so that timely evaluation and adjustment of the treatment plan can be made.

Ripotinib may also affect patients' lung health. Patients should seek medical help immediately if they develop new or worsening symptoms of dry cough, wheezing, or difficulty breathing while taking this medication. At the same time, the functional status of the liver also requires close attention. Ripotinib may cause abnormal liver function. Therefore, before starting and during treatment, doctors will arrange regular blood tests to monitor the patient's liver function. If patients find symptoms such as yellowing of their skin or the whites of their eyes, significant loss of appetite, or abnormally dark urine, they should report it to their doctor immediately.

In addition, the use of repotinib may also increase the patient's risk of fractures, especially in accidents such as falls. Therefore, patients should be extra careful in their daily lives to avoid falls and other situations that may lead to fractures. If the patient feels bone pain or has abnormal changes in the way he walks, he should inform the doctor in time for necessary examination and treatment.

In general, as a new type of therapeutic drug, reprotinib has brought new treatment options to cancer patients, but possible side effects still need to be treated with caution during use. By fully understanding these potential adverse reactions and their corresponding treatment methods, and rationally using medications and adjusting treatment plans under the guidance of doctors, patients will be able to better manage various discomforts during treatment, thereby helping to improve their quality of life.

References:

https://www.drugs.com/augtyro.html